Abstract
Bismuth compounds have been used for over 2 centuries mainly for the treatment of gastrointestinal disorders. Long duration of the therapy periods with high dosages (up to 20 g per day) had occasionally led to serious side effects in the past, including encephalopathies and nephropathies [1, 2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buge A, Rancurel G, Poisson M, Dechy H (1974) Encephalopathies myocloniques par les sels de bismuth. Nouv Presse Med 3:2300–2315
Hillemand P, Palliere M, Laquais B, Bouvet P (1977) Traitement bismuthique et bismuthemie. Semin Paris 53:1663–1669
McNulty CAM, Dent J, Wise R (1985) Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother 28:837–841
Marshall BJ, Mcgechie DB, Rogers PA, Glancy RJ (1985) Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 142:439–444
Froomes PRA, Wan AT, Keech AC, McNeil JJ, McLean AJ (1989) Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate. Eur J Clin Pharmacacol 37:533–536
Bierer DW (1990) Bismuth subsalycilate: history, chemistry, and safety. Rev Infect Dis 12 [Suppl 1]:3–8
Raedsch R, Walter-Sack I, Weber E, Blessing J (19.90) Pharmakokinetik von Wismut-Präraten bei Patienten mit Gastritis und Ulkuskrankheiten Klin Wochenschr 68:488
Fischer R, Dresow B, Wendel J, Bechthold V, Heinrich HC (1991) Bi-205/Bi-206 cyclotron production from Pb-isotopes for absorption studies in man. Int J Appl Radiat Isot (submitted)
Dresow B, Nielson P, Fischer R, Wendel J, Gabbe EE, Heinrich HC (1991) Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats. Arch Toxicol (65:646–650)
Heinrich HC, Gabbe EE, Whang DH (1965) Empfindlichkeits- und Gütekenngröβen des Hamburger 47π-Groβraum-Radioaktivitätsdetektors mit flüssigem organischen Szintillator. Atompraxis 11:430ß439
Fischer R, Heinrich HC (1990) Identifizierung und Quantifizierung inkorporierter Radionuklide im menschlichen Körper. BUNR-Schluβbericht St Sch 1024
Vienet R, Bouvet P, Istin M (1983) Cinétique et distribution du 206Bi chez le rat et le lapin: un modèle. Int J Appl Radiat Isot 34:747–753
McLean AJ, Islam S, Lambert JR (1990) Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate. Gut 31:1086
Playford RJ, Matthews CH, Camphell MJ, Delves HT, Hla KK, Hodgon HJF, Calam J (1990) Bismuth induced encephalopathy caused by tripotassium dicitrato bismuthate in a patient with chronic renal failure. Gut 31:359–360
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dresow, B., Fischer, R., Gabbe, E.E., Heinrich, H.C. (1993). Bismuth Bioavailability from 205Bi-Labelled Bismuth Compounds Used in Suppression of Helicobacter pylori and Treatment of Peptic Ulcer. In: Pajares, J.M., Peña, A.S., Malfertheiner, P. (eds) Helicobacter pylori and Gastroduodenal Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77486-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-77486-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77488-1
Online ISBN: 978-3-642-77486-7
eBook Packages: Springer Book Archive